World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
23334
World Ranking
18010
National Ranking
8978

Surena F. Matin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Surena F. Matin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 603 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Surena F. Matin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Surena F. Matin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Surena F. Matin is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medical fields, with emphasis on surgery, pulmonary and respiratory medicine, molecular biology, oncology, and radiology including nuclear medicine and imaging.

Their work covers several main topics, including:

  • Bladder and Urothelial Cancer Treatments
  • Renal cell carcinoma treatment
  • Urinary and Genital Oncology Studies
  • Urological Disorders and Treatments
  • Renal and related cancers
  • MRI in cancer diagnosis
  • Esophageal Cancer Research and Treatment

Some of their recent papers include:

  • Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma, 2020, published in Nature Medicine
  • Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline, 2023, published in The Journal of Urology
  • Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial, 2020, published in The Lancet Oncology
  • Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature, 2020, published in European Urology
  • The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis, 2021, published in The Journal of Urology

Frequent co-authors include:

  • José A. Karam
  • Philippe E. Spiess
  • Jay D. Raman
  • Wade J. Sexton
  • Viraj A. Master

Matin's research has been published predominantly in these venues:

  • The Journal of Urology
  • Urologic Oncology Seminars and Original Investigations
  • Journal of Clinical Oncology
  • British Journal of Urology
  • Urology

Best Publications

  • Guideline for management of the clinical T1 renal mass.

    Steven C Campbell;Andrew C Novick;Arie S. Belldegrun;Michael L Blute

  • Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

    Vitaly Margulis;Shahrokh F. Shariat;Surena F. Matin;Ashish M. Kamat

  • Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients.

    Inderbir S. Gill;Surena F. Matin;Mihir M. Desai;Jihad H. Kaouk

  • Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial

    Naomi B. Haas;Judith Manola;Robert G. Uzzo;Keith T. Flaherty

  • Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.

    Giovanni Lughezzani;Maximilian Burger;Vitaly Margulis;Surena F. Matin

  • Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

    Lijun Zhou;Xian-De Liu;Mianen Sun;Xuesong Zhang

  • Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy

    Mauricio Rubinstein;Inderbir S. Gill;Monish Aron;Mete Kilciler

  • Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

    Nizar M. Tannir;Eric Jonasch;Laurence Albiges;Emre Altinmakas

  • Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins

    David A. Green;Michael Rink;Evanguelos Xylinas;Surena F. Matin

  • Renal outcome 25 years after donor nephrectomy.

    David A. Goldfarb;Surena F. Matin;William E. Braun;Martin J. Schreiber

  • A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naive Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer

    David J McConkey;Woonyoung Choi;Yu Shen;I. Ling Lee

  • Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma

    Evanguelos Xylinas;Evanguelos Xylinas;Michael Rink;Michael Rink;Eugene K. Cha;Thomas Clozel

  • Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons.

    Kevin C. Zorn;Gagan Gautam;Arieh L. Shalhav;Ralph V. Clayman

  • Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy

    Stephen H. Culp;Nizar M. Tannir;E. Jason Abel;Vitaly Margulis

  • Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma.

    Surena F. Matin;Vitaly Margulis;Ashish Kamat;Christopher G. Wood

  • Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.

    Jianjun Gao;Neema Navai;Omar Alhalabi;Arlene Siefker-Radtke

  • Residual and Recurrent Disease Following Renal Energy Ablative Therapy: A Multi-Institutional Study

    Surena F. Matin;Kamran Ahrar;Jeffrey A. Cadeddu;Debra A. Gervais

  • Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma

    Eric Jonasch;Christopher G. Wood;Surena F. Matin;Shi Ming Tu

  • RECURRENCE AND SURVIVAL FOLLOWING LAPAROSCOPIC RADICAL NEPHROURETERECTOMY WITH VARIOUS FORMS OF BLADDER CUFF CONTROL

    Surena F. Matin;Inderbir S. Gill

  • Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients1

    I.S Gill;S.F Matin;M.M Desai;J.H Kaouk

Frequent Co-Authors

Christopher G. Wood
Christopher G. Wood The University of Texas MD Anderson Cancer Center
Nizar M. Tannir
Nizar M. Tannir The University of Texas MD Anderson Cancer Center
Eric Jonasch
Eric Jonasch The University of Texas MD Anderson Cancer Center
Pheroze Tamboli
Pheroze Tamboli The University of Texas MD Anderson Cancer Center
Ashish M. Kamat
Ashish M. Kamat The University of Texas MD Anderson Cancer Center
Colin P. Dinney
Colin P. Dinney The University of Texas MD Anderson Cancer Center
Jay D. Raman
Jay D. Raman Penn State Milton S. Hershey Medical Center
Louis L. Pisters
Louis L. Pisters The University of Texas MD Anderson Cancer Center
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Curtis A. Pettaway
Curtis A. Pettaway The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a broad range of health-related careers. Many students also consider allied health fields or look for flexible degree options online. An online healthcare administration degree offers training in hospital management, policy, and leadership, and can be completed faster through accelerated programs.

Nursing remains a popular pathway, especially with programs like adn to fnp programs that help registered nurses advance to family nurse practitioner roles. These flexible bridge programs enable career growth without stepping away from current jobs.

The demand for nutrition experts is also growing. Many prospective students pursue an online nutrition degree to launch careers in dietetics, wellness counseling, and food service management. These degrees often provide both foundational knowledge and practical training.

When choosing any program, accreditation is key. Students are encouraged to explore which online healthcare degree programs are recognized for their accreditation by cahme?, ensuring their education meets high industry standards and improves job prospects.

Best Scientists Citing Surena F. Matin

Trending Scientists

Recently Published Articles